GLS2 and inflammatory bowel disease: The results suggest that compared with the NRG, the signaling pathways significantly changed in the BCG, LDG, and HDG (p < 0.05, p < 0.01), such as viral protein interaction with cytokine and cytokine receptor, T cell receptor signaling pathway, intestinal immune network for lgA production, inflammatory bowel disease, and IL-17 signaling pathway.